Jacob Chacko

CIK 1608936 · PRESIDENT AND CEO · last filed 2026-01-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.81M

Companies

4

Total Filings

53

Lifetime Open-Market Net

-$3.47M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ORIC PRESIDENT AND CEO 581,711 $8.27 $4.81M -$3.49M 33 2026-01-06
FDMT Director 0 $8.83 $0 -$100.3K 6 2025-06-20
Turning Point Therapeutics, Inc. (TPTX) Delisted Director $76.01 $0 2 2020-06-17
Ignyta, Inc. (RXDX) Delisted Chief Financial Officer 70,572 $199.92 $14.11M $117.1K 11 2018-01-05

Recent Filings · Page 2 of 6

53 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-02-08 ORIC Sell (S) −40,000 -$489.3K EDGAR
2024-01-03 ORIC Grant (A) $0 EDGAR
2023-12-19 ORIC Mixed +24,128 -$124.8K EDGAR
2023-07-11 ORIC Sell (S) −15,664 -$125.5K EDGAR
2023-07-07 ORIC Sell (S) −4,336 -$34.7K EDGAR
2023-06-28 ORIC Sell (S) −20,000 -$160.6K EDGAR
2023-05-25 FDMT Grant (A) $0 EDGAR
2023-04-25 FDMT Mixed -$53.2K EDGAR
2023-02-17 ORIC Sell (S) −6,137 -$18.9K EDGAR
2023-02-02 ORIC Grant (A) $0 EDGAR
Showing 1120 of 53
Page 2 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.